Remuneration

Compensation to the CEO and senior executives

Xspray must offer levels of compensation and employment conditions on market terms to enable the recruitment and retention of senior executives and key expertise. There are currently no agreements regarding severance pay for senior executives. Compensation to senior executives consists of basic salary, share-related compensation, pension provision and other benefits.

Remuneration report

Klick the links below to download the remuneration report and the auditors opinion:

Xspray Pharma Remuneration report 2021
Auditor´s opinion under Chapter 8 Section 54 of the Swedish Companies Act (2005:551), Remuneration report 2021

Xspray Pharma Remuneration report 2020
Auditor’s opinion under Chapter 8 Section 54 of the Swedish Companies Act (2005:551), Remuneration report 2020

Long term incentive programs

LTIP 2018/2022
The LTIP 2018–2022 program, encompassing 231,922 warrants, expired on January 17, 2022. No warrants was exercised as of the end date on January 17, 2022.

LTIP 2020/2023
The LTIP 2020–2023 warrant program encompasses 72,485 warrants that can be exercised during the period from April 1, 2023 through May 14, 2023 at a subscription price of SEK 89.10 per share. There is a maximum dilution effect of 0.4% on the current number of shares.

LTIP 2021/2024
The LTIP 2021–2024 warrant program encompasses 189,340 warrants that can be exercised during the period from June 3, 2024 through July 15, 2024 at a subscription price of SEK 148.90 per share. There is a maximum dilution effect of 0.9% on the current number of shares.

Chairman LTIP 2021/2026
The Chairman LTIP 2021–2026 warrant program includes the Chairman of the Board and encompasses 13,214 warrants that can be exercised during the period from May 25, 2026 through June 15, 2026 at a subscription price of SEK 129.00 per share. There is a maximum dilution effect of 0.06% on the current number of shares.